Ab Initio Biotherapeutics, Inc. is a company that provides Antigen, Type I hypersensitivity, Health care and more. Ab Initio Biotherapeutics, Inc. is headquartered in United States California. Ab Initio Biotherapeutics, Inc. was founded in 2015. Ab Initio Biotherapeutics, Inc. has a total of 22 patents
What kind of company is Ab Initio Biotherapeutics, Inc.?
Ab Initio Biotherapeutics operates as an antigen-discovery company. Its proprietary antigen discovery platform allows for targeting multi-transmembrane...
What is Ab Initio Biotherapeutics, Inc.'s official website?